Report: Genomics World Markets TOC

1.1 Statement of Report
1.2 Objectives and Goals of Study
1.3 Methodology
1.4 Executive Summary
- 1.4.1 Market Drivers
- 1.4.2 Market Restraints
- 1.4.3 Market Size and Growth Projections
1.5 What Is a Gene?
1.6 Gene Expression
1.7 Genetic Variability
1.8 The Human Genome Project (HGP)
1.9 Gene Databases
1.10 Sequencing and Resequencing
1.11 RNA Interference (RNAi)
1.12 DNA Tags

2.1 The Development of a Genomics Market
- 2.1.1 Market Size and Growth Projections
- 2.1.2 The U.S. Genomics Market
2.2 DNA Microarray Technology
- 2.2.1 Biochips
- 2.2.2 Photolithography
- 2.2.3 Instrumentation for DNA Microarray Analysis
- 2.2.4 Lab-on-a-Chip
- 2.2.5 DNA Microarrays
2.3 Applications of DNA Microarrays
- 2.3.1 DNA Sequence Analysis
- 2.3.2 Gene Expression Analysis
- 2.3.3 Effect of DNA Sequence and Gene Expression Monitoring on the Genomics Market
2.4 Bioinformatics
2.5 Functional Genomics
- 2.5.1 Gene Knockdown
- 2.5.2 Protein-Protein Interactions
- 2.5.3 Bioinformatics
- 2.5.4 Strategies of Functional Genomics Companies
- 2.5.5 Frontiers in Functional Genomics
2.6 Comparative Genomics
2.7 Pharmacogenomics
2.8 Proteomics
2.9 Structural Genomics
2.10 Disease Targets
- 2.10.1 Paradigm Shift in Drug Development: The Evolution of Targeted Therapies
- 2.10.2 Personalized Warfarin Therapy

3.1 Pharmaceutical Applications
3.2 Diagnostics
3.3 Toxicogenomics
3.4 The Market for DNA Microarrays
3.5 DNA Chip Technology Competition
3.6 Expression Profiling
3.7 Gene Sequencing-Advantages of Chip Array Technology
3.8 Applied Markets for Genomics
3.9 Genomics and the Pharmaceutical Companies
3.10 Cancer Markets
3.11 Agricultural Markets
- 3.11.1 Plant Genomics
- 3.11.2 Food Processing
- 3.11.3 Animal Husbandry

5.1 Facilitation and Capitalization of the Convergence of Gene Expression Analysis and Proteomics
5.2 Competition
5.3 Market Opportunities for Functional Genomics
- 5.3.1 Metabolic Profiling
- 5.3.2 Anti-Fungal Targets
- 5.3.3 Nutrition
- 5.3.4 Crop Production
5.4 The Highly-Competitive Nature of the Genomics Industry
- 5.4.1 First-Generation Biotech
- 5.4.2 Second-Generation Genomics Companies
- 5.4.3 Next-Generation DNA Sequencing Companies
5.5 Strategic Alliances

6. Genomics Company Profiles

6.1 Affymetrix, Inc.
6.2 Agendia
6.3 Agilent Technologies, Inc.
6.4 Applied Biosystems Group
6.5 Bayer, AG
6.6 Biotage
6.7 Caliper Life Sciences
6.8 Celera Group
6.9 Cepheid
6.10 CLC bio
6.11 Clinical Data, Inc.
6.12 CuraGen Corporation
6.13 Cytocell Ltd.
6.14 diaDexus, Inc.
6.15 Enzo Biochem, Inc.
6.16 Exiqon A/S
6.17 GE Healthcare
6.18 Gene Link, Inc.
6.19 Gene Logic, Inc.
6.20 Genentech, Inc.
6.21 Genisphere, Inc.
6.22 Genomatix Software, Inc.
6.23 Genomic Solutions, Inc.
6.24 Gen-Probe, Inc.
6.25 Harvard Bioscience, Inc.
6.26 Helicos Biosciences Corporation
6.27 Human Genome Sciences, Inc.
6.28 Illumina, Inc.
6.29 Interleukin Genetics
6.30 LI-COR Biosciences
6.31 Luminex Corporation
6.32 Millennium Pharmaceuticals, Inc.
6.33 Monogram Biosciences, Inc.
6.34 Motorola, Inc.
6.35 MWG Biotech AG
6.36 Myriad Genetics, Inc.
6.37 Nanogen, Inc.
6.38 Nuvelo, Inc.
6.39 Orchid Cellmark
6.40 Pacific Biosciences, Inc.
6.41 QIAGEN, Inc.
6.42 Roche Diagnostics
6.43 Sequenom, Inc.
6.44 Third Wave Technologies, Inc.
6.45 Verenium Corporation
6.46 Visigen Technologies, Inc.
6.47 Brief Profiles of Companies Marketing Personalized Genomics Products
- 6.47.1 23andMe, Inc.
- 6.47.2 deCODE Genetics, Inc.
- 6.47.3 Navigenics, Inc.
6.48 Brief Profiles of Other Selected Genomics Firms
- 6.48.1 Aber Genomic Computing
- 6.48.2 Spotfire, Inc.

7.1 Market Drivers
- 7.1.1 Product Pipeline: Need for More Drug Candidates
- 7.1.2 Need for Increased Research and Development Productivity
7.2 A Genomics Market Bottleneck-Bioinformatics
7.3 Strategic Recommendations-Market Opportunities
- 7.3.1 More Comprehensive Tools Are Needed
- 7.3.2 Resolving Bottlenecks in Functional Genomics Market
7.4 Key Trends of Recent Mergers and Acquisition Deals
7.5 Chemogenomics
7.6 Pharmacogenomics
7.7 Biomarkers
7.8 Additional Genomics Market Opportunities

8.1 Types of Data and Bioinformatics Applications
- 8.1.1 Validated Core Modeling Technology
- 8.1.2 Broad Applicability
- 8.1.3 Data Management Compliant with Industry Standards
- 8.1.4 Open Architecture
- 8.1.5 Ease of Use
- 8.1.6 Increased Access
8.2 Functions of Informatics Software
- 8.2.1 Data Management
- 8.2.2 Transformation of Data into Knowledge
- 8.2.3 Collaboration Among Researchers
- 8.2.4 Interface for Online Data Sources
8.3 Target Markets for Informatics Software
- 8.3.1 Pharmaceutical Companies
- 8.3.2 Biotechnology Companies
- 8.3.3 Academic and Government Research Institutions
- 8.3.4 Agricultural, Environmental and Industrial Biotechnology Companies
8.4 Products of Bioinformatics
- 8.4.1 Sequences and Structure of Genes and Proteins
- 8.4.2 3-D Molecular Structures
- 8.4.3 Genome Structures and Functions
- 8.4.4 Bibliographic Data
8.5 Bioinformatics Processes
8.6 Informatics Tools and Functionalities
- 8.6.1 Sequence to Structure
- 8.6.2 Lead Identification and Optimization
- 8.6.3 Development and Formulation
- 8.6.4 Improving Materials and Processes in the Chemicals Industry
- 8.6.5 Other Materials-Based Industries
8.7 Role of Bioinformatics in the Value Chain
8.8 Bioinformatics Market Segments
- 8.8.1 Database
- 8.8.2 Hardware
- 8.8.3 Software
- 8.8.4 Bioinformatics Services
8.9 Bioinformatics Business Models
- 8.9.1 Changing Business Models
- 8.9.2 Selected Business Strategies

Figure 2.1: Major Areas of Functional Genomics and Their Relationship to Bioinformatics and Industry
Figure 8.1: Role of Bioinformatics in the Biotechnology Value Chain

Table 2.1: Genomics Sector Global Market Size, 2001 to 2010
Table 2.2: Companies Marketing DNA Microarray Software
Table 2.3: Selected Competitors in the DNA Microarray Market
Table 2.4: Companies Offering DNA Sequencing Products
Table 2.5: Competitors in the SNP-Genotyping Segment
Table 2.6: Companies that Market MAQC-tested Gene Expression Microarrays
Table 2.7: Worldwide Market for Bioinformatics, 2005 to 2010
Table 2.8: Selected Companies Marketing New Functional Genomics Tools
Table 3.1: Genomics Pharmaceutical Market Sector Leaders and Promising Newcomers
Table 3.2: Summary of Assays for HIV Viral Load Testing
Table 3.3: Global Market for HIV Diagnostic Testing, 2000 to 2012
Table 3.4: Summary of Molecular Diagnostics Testing
Table 3.5: Global Market for Molecular Diagnostics Testing, 2000 to 2012
Table 3.6: U.S. Market for Molecular Diagnostics Testing, 2004 to 2012
Table 3.7: Applied Markets for Genomics
Table 3.8: Competitors in the Field of Identity Genomics Testing
Table 3.9: Opportunities for Molecular-Targeting Therapeutics for Cancer
Table 3.10: Emerging Companies in the Anti-Cancer Sector
Table 8.1: Data Source and Bioinformatic Investigations
Table 8.2: Bioinformatics Activities, Subactivities and Key Players

Genomics World Markets